DK1005540T3 - IKK-beta-proteiner, nukleinsyrer og fremgangsmåder - Google Patents

IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Info

Publication number
DK1005540T3
DK1005540T3 DK98933095T DK98933095T DK1005540T3 DK 1005540 T3 DK1005540 T3 DK 1005540T3 DK 98933095 T DK98933095 T DK 98933095T DK 98933095 T DK98933095 T DK 98933095T DK 1005540 T3 DK1005540 T3 DK 1005540T3
Authority
DK
Denmark
Prior art keywords
ikk
beta
nucleic acids
methods
disclosed
Prior art date
Application number
DK98933095T
Other languages
Danish (da)
English (en)
Inventor
David V Goeddel
John Woronicz
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Application granted granted Critical
Publication of DK1005540T3 publication Critical patent/DK1005540T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98933095T 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder DK1005540T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88711497A 1997-07-01 1997-07-01
US08/890,853 US5851812A (en) 1997-07-01 1997-07-10 IKK-β proteins, nucleic acids and methods
EP98933095A EP1005540B1 (fr) 1997-07-01 1998-07-01 Proteines ikk-beta, acides nucleiques et procedes
PCT/US1998/013783 WO1999001542A1 (fr) 1997-07-01 1998-07-01 PROTEINES IKK-β, ACIDES NUCLEIQUES ET PROCEDES

Publications (1)

Publication Number Publication Date
DK1005540T3 true DK1005540T3 (da) 2004-10-18

Family

ID=27128822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98933095T DK1005540T3 (da) 1997-07-01 1998-07-01 IKK-beta-proteiner, nukleinsyrer og fremgangsmåder

Country Status (10)

Country Link
US (3) US5851812A (fr)
EP (1) EP1005540B1 (fr)
JP (2) JP3472584B2 (fr)
AT (1) ATE269402T1 (fr)
AU (1) AU725477B2 (fr)
CA (1) CA2294516C (fr)
DE (1) DE69824597T2 (fr)
DK (1) DK1005540T3 (fr)
ES (1) ES2218839T3 (fr)
WO (1) WO1999001542A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920518A1 (fr) * 1996-08-26 1999-06-09 Signal Pharmaceuticals, Inc. Agent caracterise par un signal i(kappa)b kinase ikk] inductible par stimulus
US5972674A (en) 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
CA2281955C (fr) * 1997-02-25 2009-09-08 The Regents Of The University Of California Kinase inhibitrice de nf-kb (ikb), sous-unites de la kinase ikb et procedes d'utilisation
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US6087169A (en) * 1997-08-04 2000-07-11 Smithkline Beecham Plc HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide
EP0897009A3 (fr) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6242253B1 (en) * 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
JP2003526608A (ja) * 1998-10-15 2003-09-09 バイオイメージ エイ／エス 再分布及び／又は標的化での干渉によって得られる特異的治療の介入
CN102816743A (zh) * 1998-12-10 2012-12-12 信号药物公司 调节NF-κB的人遍在蛋白连接酶E3
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
CA2360934A1 (fr) 1999-02-22 2000-08-31 Lin-Hua Zhang Derives polycyclo heterocycliques utilises en tant qu'agents anti-inflammatoires
JP2002539206A (ja) 1999-03-12 2002-11-19 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症剤としての芳香族複素環化合物
ATE278674T1 (de) * 1999-03-12 2004-10-15 Boehringer Ingelheim Pharma Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
CA2374737C (fr) * 1999-07-09 2008-02-12 Boehringer Ingelheim Pharmaceuticals, Inc. Nouveau procede de synthese de composes d'uree a substitution heteroaryle
US6468755B1 (en) 1999-08-10 2002-10-22 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
AU2007202315B2 (en) * 1999-09-30 2009-11-19 Yale University Anti-inflammatory compounds and uses thereof
US20030152910A1 (en) * 1999-12-06 2003-08-14 Matthias Stein-Gerlach Method for identification and quantification of kinase inhibitors
AU2368201A (en) * 1999-12-23 2001-07-09 Xantos Biomedicine Ag Screening method for nucleic acids
US6525046B1 (en) 2000-01-18 2003-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US7049395B2 (en) 2000-05-02 2006-05-23 Yale University Anti-inflammatory compounds and uses thereof
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
PL364111A1 (en) * 2001-02-01 2004-12-13 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of ikappab kinase (ikk)
DE10115073A1 (de) * 2001-03-27 2002-10-10 Procorde Gmbh Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren
WO2002082082A2 (fr) * 2001-04-09 2002-10-17 Boehringer Ingelheim Pharmaceuticals, Inc. Analyse par polarisation de fluorescence
AU2002352519A1 (en) * 2001-11-09 2003-05-26 The General Hospital Corporation Methods for treating ischemic reperfusion injury using ikb kinase-beta inhibitors
EP1455791A1 (fr) * 2001-12-11 2004-09-15 Boehringer Ingelheim Pharmaceuticals Inc. Methode d'administration de birb 796 bs
EP1480973B1 (fr) * 2002-02-25 2008-02-13 Boehringer Ingelheim Pharmaceuticals Inc. Composes de cycloalkyle uree benzofusionnes a disubstitution en position 1,4 utiles dans le traitement de maladies mediees par la cytokine
WO2005101019A2 (fr) * 2004-04-12 2005-10-27 University Of Vermont And State Agricultural College Detection de proteines nitrosylees
EP2001455A2 (fr) 2006-03-15 2008-12-17 Theralogics, Inc. Méthodes de traitement des maladies d'atrophie musculaire au moyen d'inhibiteurs de l'activation de nf-kb
WO2007137220A2 (fr) * 2006-05-22 2007-11-29 Alnylam Pharmaceuticals, Inc. Compositions et méthodes inhibant l'expression du gène ikk-b
EP3656385A1 (fr) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Modulateurs stéroïdiens non hormonaux de nf-kb pour le traitement d'une maladie
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920518A1 (fr) * 1996-08-26 1999-06-09 Signal Pharmaceuticals, Inc. Agent caracterise par un signal i(kappa)b kinase ikk] inductible par stimulus
CA2281955C (fr) * 1997-02-25 2009-09-08 The Regents Of The University Of California Kinase inhibitrice de nf-kb (ikb), sous-unites de la kinase ikb et procedes d'utilisation
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
EP0897009A3 (fr) * 1997-08-04 1999-06-09 Smithkline Beecham Plc HKABY60 polypeptides
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells

Also Published As

Publication number Publication date
EP1005540A4 (fr) 2003-04-02
ES2218839T3 (es) 2004-11-16
CA2294516C (fr) 2003-10-21
JP2003274984A (ja) 2003-09-30
EP1005540B1 (fr) 2004-06-16
EP1005540A1 (fr) 2000-06-07
DE69824597T2 (de) 2005-06-09
JP3472584B2 (ja) 2003-12-02
US5939302A (en) 1999-08-17
US5916760A (en) 1999-06-29
ATE269402T1 (de) 2004-07-15
DE69824597D1 (de) 2004-07-22
WO1999001542A1 (fr) 1999-01-14
US5851812A (en) 1998-12-22
CA2294516A1 (fr) 1999-01-14
JP2001510347A (ja) 2001-07-31
AU8283798A (en) 1999-01-25
AU725477B2 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
WO1999033982A3 (fr) Genes humains et produits d'expression genique i
EP0804609A4 (fr) NOUVEAUX GENES DE REPONSE p53
DE69838483D1 (de) Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
DE69808743D1 (en) Netrinrezeptoren
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
ATE356137T1 (de) Neue moleküle aus der familie der tango-77- ähnlichen proteine und ihre verewendungen.
WO1996015144A3 (fr) Marqueur du gene du chromosome 21, compositions et procedes associes
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
CA2281895A1 (fr) Ikb kinases
MXPA02008239A (es) Gen humano de la esquizofrenia.
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO2000052047A3 (fr) Proteine humaine et molecules d'acide nucleique associees a dickkopf et leurs utilisations
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
ATE245190T1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
WO2001014420A3 (fr) Nouveaux plexines et leurs utilisations
WO1998006841A3 (fr) Deux proteines humaines du genre nsp
CA2294476A1 (fr) Recepteurs de semaphorine
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2000019988A8 (fr) NOUVELLES MOLECULES SPECIFIQUES DE Th2 ET LEURS UTILISATIONS
WO1998011234A3 (fr) Proteines kinases humaines
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2001036478A3 (fr) Methodes et compositions se rapportant a des polypeptides et a des polynucleotides similaires au facteur bactericide augmentant la permeabilite
WO2001000662A3 (fr) Utilisation de polypeptides fgh-8 humains comme agents neurotrophiques